A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. (Q48166495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

title

A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

Xavier Estivill i Pallejà

30 December 2019

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

Mikel Urretavizcaya Sarachaga

30 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

Rafael de Cid

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

Jose Manuel Menchon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Gratacòs M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

González JR

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

Crespo JM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

Bayés M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

Vallejo J

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

publication date

15 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

101-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17505499 AND SRC:MED&resulttype=core&format=json

Global burden of depressive disorders in the year 2000

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Treatment resistant depression: methodological overview and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Predictors of response to antidepressants general principles and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Pharmacogenetics of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

A Molecular and Cellular Theory of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Trophic factors and neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Neurotrophin-3: a neurotrophic factor related to NGF and BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Maternal serum concentrations of BDNF and depression in the perinatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

BDNF gene is a risk factor for schizophrenia in a Scottish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Multiple promoters direct tissue-specific expression of the rat BDNF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Depression: a case of neuronal life and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Sample size requirements for matched case-control studies of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

A multiplex assay with 52 single nucleotide polymorphisms for human identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

A sequencing method based on real-time pyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Linkage Disequilibrium of the Brain-Derived Neurotrophic FactorVal66MetPolymorphism in Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

Molecular cloning and expression of brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

The genetics of depression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Regulation of Neuropeptides in Adult Rat Forebrain by the Neurotrophins BDNF and NGF

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Psychosocial and vascular risk factors for depression in the elderly

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500460

7 January 2021